BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

8 articles for LW Woo

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.EBI
University of Bath
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.EBI
University of Bath
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory ActivityEBI
TBA
Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitorsBDB
Iteos Therapeutics
Heterocyclic compounds useful as PDK1 inhibitorsBDB
Sunesis Pharmaceuticals
Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication.BDB
Schering-Plough Research Institute
Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors.BDB
Astrazeneca
Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.BDB
Roche Products